Pending actions
8
Historical total
12
Resolved / remanded
4
Newly Centralized. Consolidated within the last 18 months. Of 12 lawsuits ever part of this litigation, 8 remain active.
About this litigation
Denosumab Patent Litigation is a federal multidistrict litigation classified by the Judicial Panel on Multidistrict Litigation as a Intellectual Property docket. It was centralized on February 6, 2025 before Christine P. O'Hearn, U.S. District Judge, in the D. New Jersey.
As of the August 3, 2026 JPML report, 8 individual lawsuits are pending in this MDL. Cases coordinated in an MDL keep their separate identity — they are managed together only for pretrial proceedings. Learn how MDLs work.
Related Intellectual Property MDLs
View categoryRare Breed Triggers Patent Litigation
59
pending actions
MDL 3176
E.D. Texas
OpenAI, Inc., Copyright Infringement Litigation
19
pending actions
MDL 3143
S.D. New York
Neo Wireless, LLC, Patent Litigation
7
pending actions
MDL 3034
E.D. Michigan
Aflibercept Patent Litigation
3
pending actions
MDL 3103
N.D. West Virginia